Item Infomation
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ignacio, Martin-Loeches | - |
| dc.contributor.author | Andrew F., Shorr | - |
| dc.contributor.author | Richard G., Wunderink | - |
| dc.date.accessioned | 2023-03-22T09:08:46Z | - |
| dc.date.available | 2023-03-22T09:08:46Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.uri | https://link.springer.com/article/10.1186/s13613-022-01084-8 | - |
| dc.identifier.uri | https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 | - |
| dc.description | CC BY | vi |
| dc.description.abstract | The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated hospital-acquired/ventilator-associated bacterial pneumonia (vHABP/VABP). Here, we evaluated treatment outcomes by degree of respiratory or cardiovascular dysfunction. | vi |
| dc.language.iso | en | vi |
| dc.publisher | Springer | vi |
| dc.subject | pivotal ASPECT-NP tria | vi |
| dc.subject | ventilator-associated bacterial pneumonia | vi |
| dc.title | Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial | vi |
| dc.type | Book | vi |
| Appears in Collections | ||
| OER- Y học- Điều dưỡng | ||
Files in This Item:
